« All Blogs Aug 1, 2014
2016 Changes Impact Collaborative Staging
Collaborative Staging

The New Year always brings change. 

For instance, beginning January 1, 2016, Collaborative Staging will no longer be required for cancer registry data. Moving forward the focus will be on the American Joint Committee on Cancer (AJCC) Staging. Standard-setters in the U.S. and Canada will require AJCC Tumor, Lymph Node and Metastasis (TNM) and Summary Stage coding to be recorded in the cancer registry abstract. 

The Industry Responds to this Change 

In response, a Collaborative Staging transition group has been formed by organizations within the cancer surveillance community to provide updates, share information and develop best practices to address this change. 

Communication updates and ongoing efforts to coordinate the transition are being shared through the Collaborative Staging group’s newsletter. The latest update addresses the confusion surrounding the terms “Directly Coded” or “Directly Assigned” AJCC Stage. 

These terms were originally intended to differentiate between the derived AJCC Stage obtained through the use of the Collaborative Staging System versus the collection of AJCC Stage following the AJCC 7th edition manual. To avoid any confusion, moving forward, “the collection of AJCC Stage and SEER Summary Stage” will mean the collection of stage without the use of the Collaborative Staging System. 

CHAMPS Responds to this Change

In order to prepare for this Collaborative Staging change, CHAMPS Oncology has scheduled cancer registry education sessions for their 40-plus staff members in Cleveland, Columbus and Indianapolis. CHAMPS’ staff will continue to learn how to identify inconsistencies and choose the correct staging elements for their clients.

« Previous Blog Post CoC Source Provides Important Reminders
Next Blog Post » Pass or Fail: NCRA Reveals Certified Tumor Registrar Exam Scores